Biapenem in complicated urinary tract

Abstract

Clinical effect and safety of biapenem (BIPM), a new injectable carbapenem antibiotic, was evaluated on 17 patients with complicated urinary tract infection.BIPM was administered by intravenous drip infusion at a dose of 300-450mg twice daily for 5days.
In 14 cases which were evaluable by the criteria of the Japanese UTI committee, excellent results was observed in 8, moderate in 6 patients, so the effectiveness rate being 100%. Bacteriologically, all 24 strains were eradicated. We noted no adverse reactions or abnormalities of laboratory findings.